p-value Group has been acquired by Publicis Groupe
p-value Group, one of the largest independent medical communications agencies in North America, has been acquired by Publicis Groupe (ENXTPA:PUB) for its strong strategic fit, global scale and cultural alignment. The acquisition enhances Publicis Groupe’s medical communications capabilities in the USA and supports its broader strategy of integrating science-first solutions across its global network.
Founded in 2004 by Linda Corvari, p-value is a leading full-service provider of medical and scientific communications, serving marquee clients across the life sciences sector. The company specializes in medical strategy, scientific communications, content development and speaker bureau management, earning a strong reputation for scientific rigor, exceptional client service and a culture of excellence. p-value maintains diverse and expanding expertise across therapeutic areas, with particularly strong experience in dermatology.
Publicis Groupe, founded in 1926 and headquartered in Paris, France, is the world's second-largest advertising holding company by revenue. The group offers a broad range of services, including traditional and digital advertising, public relations and consulting. It employs approximately 108,000 people worldwide, with over 80% of its revenue generated from developed markets, particularly North America and Europe.
Oaklins Intrepid in Los Angeles acted as the exclusive sell-side advisor in this transaction, highlighting the team’s deep domain expertise in the pharmaceutical services sector and broader marketing agency landscape.
Talk to the deal team
Adam Abramowitz
Oaklins Intrepid
Greg Passani
Oaklins Intrepid
Related deals
Banook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Learn moreThyssen'sche Handelsgesellschaft has acquired h/p/cosmos sports & medical GmbH
Thyssen’sche Handelsgesellschaft mbH (THG), a German strategic holding company, has acquired a majority stake in h/p/cosmos sports & medical GmbH. Founder and former sole shareholder Franz Harrer, who built h/p/cosmos into a global leader in niche medical and sports diagnostics equipment, remains invested as a minority partner. THG will support the company’s international growth and innovation plans, while the existing management team continues to run the business.
Learn moreValtronic has sold two operating subsidiaries to Cicor Group
Cicor Group has acquired the US and Moroccan subsidiaries of Valtronic. Through this transaction, Valtronic’s shareholders have secured the long-term development and success of the two entities, while Cicor gains access to the US market and doubles its production capacity in Morocco.
Learn more